| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +16.6% |
| Cost of Revenue | $3.8M | +18.3% |
| R&D Expense | $657K | +28.6% |
| SG&A Expense | $3.5M | +0.1% |
| Operating Income | -$68K | +89.7% |
| Interest Expense | $145K | +4.3% |
| Pre-tax Income | -$209K | -59.5% |
| Net Income | -$209K | -59.5% |
| EPS (Basic) | -$0.03 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.1M | +84.3% |
| Inventory | $1.1M | -9.0% |
| Current Assets | $3.6M | +1.1% |
| Total Assets | $5.2M | -4.0% |
| Current Liabilities | $4.7M | -3.0% |
| Total Liabilities | $4.8M | -9.0% |
| Stockholders' Equity | -$3.9M | +6.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13K | -98.6% |
| Capital Expenditures | $166K | +107.5% |
| Investing Cash Flow | -$171K | -106.0% |
| Financing Cash Flow | -$200K | — |
| Free Cash Flow | -$153K | -118.0% |
| -50.0% |
| EPS (Diluted) | -$0.03 | -50.0% |